These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2570554

  • 1. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
    Haruta K, Baba A, Akima M, Koga T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1989; 299():169-84. PubMed ID: 2570554
    [Abstract] [Full Text] [Related]

  • 2. Comparison of cardiovascular effects of SGB-1534 and prazosin, selective alpha 1-adrenoceptor antagonists, in anesthetized dogs.
    Imagawa J, Nabata H, Sakai K.
    Jpn J Pharmacol; 1987 May; 44(1):35-41. PubMed ID: 2887683
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
    Aono J, Nabata H, Ishizuka N, Sakai K.
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of alpha 1-adrenoceptor blockade on blood pressure and iliac vascular resistance in normotensive and Goldblatt hypertensive dogs; influence of dietary salt and DOCA-salt.
    Zeigler DW, Zimmerman BG.
    J Hypertens; 1987 Aug; 5(4):407-12. PubMed ID: 2889779
    [Abstract] [Full Text] [Related]

  • 9. In vivo experiments for the evaluation of alpha 1-adrenoceptor antagonistic effects of SGB-1534 on canine urethra.
    Imagawa J, Akima M, Sakai K.
    Eur J Pharmacol; 1989 Aug 11; 167(1):167-72. PubMed ID: 2570705
    [Abstract] [Full Text] [Related]

  • 10. [The hypotensive effects and mechanism of SGB-483, a newly-synthesized hypotensive agent].
    Chin W, Nakagawa Y, Mitomi A, Imai S.
    Nihon Yakurigaku Zasshi; 1982 May 11; 79(5):441-9. PubMed ID: 6127291
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alpha-1B adrenoceptors mediate neurogenic constriction in mesenteric arteries of normotensive and DOCA-salt hypertensive mice.
    Pérez-Rivera AA, Fink GD, Galligan JJ.
    Auton Neurosci; 2005 Aug 31; 121(1-2):64-73. PubMed ID: 16095979
    [Abstract] [Full Text] [Related]

  • 13. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide.
    Bolt GR, Itoh H, Lederis K, MacCannell KL.
    J Pharmacol Exp Ther; 1987 Jul 31; 242(1):284-91. PubMed ID: 3039111
    [Abstract] [Full Text] [Related]

  • 14. CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology.
    Ryan MJ, Bjork FA, Cohen DM, Coughenour LL, Major TC, Mathias NP, Mertz TE, Olszewski BJ, Singer RM, Evans DB.
    J Pharmacol Exp Ther; 1986 Aug 31; 238(2):473-9. PubMed ID: 2874210
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of ergonovine-induced contraction in the mesenteric artery from deoxycorticosterone acetate-salt hypertensive rat.
    Watts SW, Webb RC.
    J Pharmacol Exp Ther; 1994 May 31; 269(2):617-25. PubMed ID: 8182528
    [Abstract] [Full Text] [Related]

  • 16. Essential oil of Croton nepetaefolius decreases blood pressure through an action upon vascular smooth muscle: studies in DOCA-salt hypertensive rats.
    Lahlou S, Leal-Cardoso JH, Magalhães PJ.
    Planta Med; 2000 Mar 31; 66(2):138-43. PubMed ID: 10763587
    [Abstract] [Full Text] [Related]

  • 17. Postsynaptic alpha-adrenoceptor subtypes in the internal carotid, mesenteric, splenic, renal and femoral vascular beds of the dog.
    Polonia JJ, Guerreiro M, Guimarães S, Garrett J.
    Arch Int Pharmacodyn Ther; 1986 Jan 31; 279(1):5-16. PubMed ID: 3008676
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive activity of tibalosine (CP 804 S) in the rat. Possible involvement of a central alpha 1-adrenergic receptor blockade.
    Chatelain P, Claeys M, van Dorsser W, Roba J.
    Arch Int Pharmacodyn Ther; 1984 Apr 31; 268(2):271-86. PubMed ID: 6145397
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
    Yen MH, Sheu JR, Peng IH, Lee YM, Chern JW.
    J Pharm Pharmacol; 1996 Jan 31; 48(1):90-5. PubMed ID: 8722503
    [Abstract] [Full Text] [Related]

  • 20. Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments.
    Shibata S, Satake N, Suh TK, Ishida Y, Ueda S, Follmer C, Flores F.
    Gen Pharmacol; 1986 Jan 31; 17(2):143-9. PubMed ID: 2870954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.